|
Quotes & Info
|
| ARRY > SEC Filings for ARRY > Form 8-K/A on 1-Feb-2013 | All Recent SEC Filings |
1-Feb-2013
Change in Directors or Principal Officers
(d) On January 31, 2013, the Board of Directors of Array BioPharma appointed John Orwin, whose term as a director commenced November 6, 2012, to the Compensation Committee of the Board of Directors.
|
|